For following the competition: what moved in each program, several studies read as one move.
- CKD-843
- lobeglitazone
- empagliflozin
- + 15 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Chong Kun Dang Pharmaceutical to watchlistEvery Monday by email · turn it off any timePro · free during the beta